Amarin Corp plc (AMRN) Misses Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Price: $13.63 -1.73%
Financial Fact:
Provision for income taxes: 1.02M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Provision for income taxes: 1.02M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Amarin Corp plc (NASDAQ: AMRN) reported Q3 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13).
Recognized $14.1 million in product revenue from Vascepa® (icosapent ethyl) sales in Q3 2014 compared to $12.6 million in Q2 2014 and $8.4 million in Q3 2013, an increase of 12% and 68%, respectively
For earnings history and earnings-related data on Amarin Corp plc (AMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
